Non-CME Educational Activities

All events are scheduled during times that do not conflict with Symposium CME educational programing.

These optional non-CME educational activity and are not approved for CME or continuing education credit. The content of these optional non-CME activities and opinions expressed by presenters are those of the sponsor or presenters.

---

Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of Kisqali

Thursday, September 7 • breakfast event

Sponsored by Novartis

---

Expanded Horizons: A Post-endocrine Option for Patients with HR+/HER2- mBC

Thursday, September 7 • lunch event

Sponsored by Gilead

---

Latest Data in HR+, HER2-, High-Risk EBC Discover the Potential Impact on Your Clinical Approach

Friday, September 8 • breakfast event

sponsored by Lilly

---

Nerlynx: Case Studies in HER2+ Early Breast Cancer

Friday, September 8 • lunch event

sponsored by Puma Biotechnology

---

Adjuvant Therapy in Certain Patients With HER2-Negative, High-Risk Early Breast Cancer

Friday, September 8 • cocktail event

sponsored by AstraZeneca

---

A Treatment Option for Certain Patients with ESR1-mutated mBC

Saturday, September 9 • breakfast event

sponsored by Stemline

---

Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

Saturday, September 9 • lunch event

Speaker: Anne O'Dea, MD, University of Kansas Cancer Center

sponsored by Pfizer